Antithrombin Iii Human

3 trials 2 recruiting BHaematology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

13 Countries

Phase III

Phase III: 3

Oversight events:

6 temporary halts across 1 trial

View oversight register →

Indications tested

Acquired antithrombin III deficiency 1 Heparin resistance 1

Sponsors using this IMP

Octapharma AG 2 Genzyme Corp. 1

All trials

3 total

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery Recruiting

2024-515830-34-00 Phase III 8 countries Octapharma AG
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo … Recruiting

2023-507560-39-00 Phase III 8 countries Octapharma AG
Long-term Safety and Efficacy Study of Fitusiran in Patients with Hemophilia A or B, with or without Inhibitory Antibodies to Factor VIII or… Ended

2023-508884-59-00 Phase III 5 countries Genzyme Corp.

Showing 1–3 of 3 trials

← All drugs A–Z